Ex Ante Evaluation of the Economic Impact of Agricultural Biotechnology: The Case of Porcine Somatotropin

Catherine M. Lemieux and Michael Wohlgenant ()

American Journal of Agricultural Economics, 1989, vol. 71, issue 4, 903-914

Abstract: Introduction of a new growth hormone, porcine somatotropin, will have a significant impact on the U.S. pork industry. Ex ante effects are estimated using a linear elasticity model, which accounts for interrelationships between domestic and international markets for hogs and pork, different adoption rates and lengths of run for supply, and consumer demand shifts from leaner pork. The paper shows how to use experimental data to quantify production function and supply shifts. Results indicate that, for a five-year adjustment period, producers' surplus will increase between $250 million and $720 million; consumers' surplus will increase between $900 million and $1.95 billion.

Date: 1989
References: Add references at CitEc
Citations: View citations in EconPapers (54)

Downloads: (external link)
http://hdl.handle.net/10.2307/1242668 (application/pdf)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:oup:ajagec:v:71:y:1989:i:4:p:903-914.

Access Statistics for this article

American Journal of Agricultural Economics is currently edited by Madhu Khanna, Brian E. Roe, James Vercammen and JunJie Wu

More articles in American Journal of Agricultural Economics from Agricultural and Applied Economics Association Contact information at EDIRC.
Bibliographic data for series maintained by Oxford University Press ().